Globally, 20 million people live with HIV but are not getting treatment. They may not know they have the virus or the stigma associated with it might have discouraged them from seeking medical help. These people are considered the next frontier in the fight to end the epidemic.
UNAids is working towards achieving its 90-90-90 targets by 2020. The goal is for 90% of all people with HIV to know their status, that 90% of all people diagnosed with HIV will receive sustained antiretroviral therapy and that 90% of all people receiving antiretroviral therapy will have achieved viral suppression (whereby the virus is at an undetectable level).
But money is tight. Donors pledged almost $13bn to the Global Fund to Fight Aids, Tuberculosis and Malaria earlier this month, but $19.3bn will be needed in 2017 alone (pdf) for efforts to meet UNAids treatment targets in low- and middle-income countries. Global support for HIV/Aids is falling. In South Africa, for example, there is a 30% shortfall in the funding needed to achieve these aims.
So how do we do more with less money and ensure effective spending? Which interventions are better value for money? And where might alternative funding be found?
Join an expert panel on Thursday 6 October, from 3pm to 4.30pm BST, to discuss these questions and more.
The live chat is not video or audio-enabled but will take place in the comments section (below). Want to recommend someone for the panel or ask a question in advance? Get in touch via globaldevpros@theguardian.com or @GuardianGDP on Twitter. Follow the discussion using the hashtag #globaldevlive.
Panel to be announced
